home / stock / eltp / eltp news

ELTP News and Press, Elite Pharmaceuticals Inc. From 04/20/23

Stock Information
Company Name: Elite Pharmaceuticals Inc.
Stock Symbol: ELTP
Market: OTC
Website: elitepharma.com
Menu
ELTP ELTP Quote ELTP Short ELTP News ELTP Articles ELTP Message Board
Get ELTP Alerts

News, Short Squeeze, Breakout and More Instantly...
ELTP - Elite Pharmaceuticals Files ANDA with US FDA to Market Antimetabolite Product

NORTHVALE, NJ / ACCESSWIRE / April 20, 2023 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCBB:ELTP), a specialty pharmaceutical company developing niche generic products, today announced that it filed an Abbreviated New Drug Application (ANDA) with the US Food and Drug Administrati...
ELTP - Elite Pharmaceuticals, Inc. (ELTP) Q3 2023 Earnings Call Transcript

Elite Pharmaceuticals, Inc. (ELTP) Q3 2023 Earnings Conference Call Feb 15, 2023, 11:30 AM ET Company Participants Nasrat Hakim - President and Chief Executive Officer Robert Chen - Chief Financial Officer Conference Call Participants Presentation Ope...

ELTP - Elite Pharmaceuticals GAAP EPS of $0.00, revenue of $9.25M

Elite Pharmaceuticals press release ( OTCQB:ELTP ): Q3 GAAP EPS of $0.00. Revenue of $9.25M (+3.1% Y/Y). For further details see: Elite Pharmaceuticals GAAP EPS of $0.00, revenue of $9.25M

ELTP - Elite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal Year 2023 ended December 31, 2022 and Provides Conference Call Information

Conference Call Scheduled for Wednesday, February 15 at 11:30 AM EST NORTHVALE, NJ / ACCESSWIRE / February 14, 2023 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty pharmaceutical company developing niche generic products, announced results for the third qua...
ELTP - Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Third Quarter 2023 Financial Results on February 15, 2023

Financials for Third Quarter Fiscal Year 2023 Ended December 31, 2022 will be released on February 14, 2023 NORTHVALE, NJ / ACCESSWIRE / February 8, 2023 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty pharmaceutical company developing niche generic product...

ELTP - Elite Pharmaceuticals Files ANDA with US FDA to Market Dopamine Agonist

NORTHVALE, NJ / ACCESSWIRE / December 22, 2022 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty pharmaceutical company developing niche generic products, today announced that it filed an Abbreviated New Drug Application (ANDA) with the US Food and Drug Administr...

ELTP - Elite Pharmaceuticals GAAP EPS of $0.00, revenue of $8.59M

Elite Pharmaceuticals press release ( OTCQB:ELTP ): FQ2 GAAP EPS of $0.00. Revenue of $8.59M (+0.4% Y/Y). As of September 30, 2022, and March 31, 2022, the Company had $0.41M and $0.41M, of restricted cash, respectively, related to debt service reserve in regard to th...
ELTP - Elite Pharmaceuticals, Inc. (ELTP) Q2 2023 Earnings Call Transcript

Elite Pharmaceuticals, Inc. (ELTP) Q2 2023 Earnings Conference Call November 15, 2022 11:30 AM ET Company Participants Nasrat Hakim – President and Chief Executive Officer Robert Chen – Chief Financial Officer Conference Call Participants ...

ELTP - Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2023 Ended September 30, 2022 and Provides Conference Call Information

Conference Call Scheduled for Tuesday, November 15 at 11:30 AM EST NORTHVALE, NJ / ACCESSWIRE / November 15, 2022 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company")(OTCQB:ELTP), a specialty pharmaceutical company developing niche generic products, announced results for the second ...

ELTP - Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Second Quarter 2023 Financial Results on November 15, 2022

Financials for Second Quarter Fiscal Year 2023 Ended September 30, 2022 will be released on November 14, 2022 NORTHVALE, NJ / ACCESSWIRE / November 8, 2022 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty pharmaceutical company developing niche generic ...
Previous 10 Next 10